Pennant Capital Management’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-1,949,569
| Closed | -$56.2M | – | 47 |
|
|
2016
Q2 | $56.2M | Sell |
1,949,569
-133,505
| -6% | -$3.85M | 1.44% | 26 |
|
|
2016
Q1 | $66.7M | Sell |
2,083,074
-238,507
| -10% | -$7.64M | 1.9% | 28 |
|
|
2015
Q4 | $99.3M | Sell |
2,321,581
-722,200
| -24% | -$30.9M | 2.53% | 23 |
|
|
2015
Q3 | $107M | Sell |
3,043,781
-160,315
| -5% | -$5.64M | 2.27% | 23 |
|
|
2015
Q2 | $147M | Buy |
3,204,096
+1,179,096
| +58% | +$54.1M | 2.92% | 16 |
|
|
2015
Q1 | $94.9M | Buy |
2,025,000
+1,491,900
| +280% | +$69.9M | 1.78% | 23 |
|
|
2014
Q4 | $16.9M | Buy |
+533,100
| New | +$16.9M | 0.32% | 38 |
|